|
|
||||||||
J Thorac Cardiovasc Surg 1999;117:324-331
© 1999 Mosby, Inc.
SURGERY FOR CONGENITAL HEART DISEASE |
From the Divisions of Cardiothoracic Surgerya and Pediatric Cardiology,b University of CaliforniaSan Francisco, San Francisco, Calif.
Read at the Seventy-eighth Annual Meeting of The American Association for Thoracic Surgery, Boston, Mass, May 3-6, 1998.
Received for publication May 26, 1998. revisions requested July 6, 1998. revisions received Sept 23, 1998. Accepted for publication Oct 15, 1998. Address for reprints: V. Mohan Reddy, MD, Division of Cardiothoracic Surgery, 505 Parnassus Ave, M593, San Francisco, CA 94143-0118.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Our approach to infants with symptoms has been to perform total corrective surgical repair whenever biventricular repair is possible. This approach evolved from our experience indicating that these infants often have either associated extracardiac malformations or prematurity-related issues that, when combined with congenital heart disease, lead to severe and often prolonged morbidity when the cardiac defect is not repaired. Because many of these noncardiac problems cannot themselves be corrected immediately, it is intuitively logical that the overall well-being of the infant would be optimized by correcting the cardiac status.
| Patients and methods |
|---|
|
|
|---|
2500 g) babies with potentially correctable congenital heart defects underwent complete repair. Patients with isolated patent ductus arteriosus were excluded. Weight ranged from 700 to 2500 g (median 2100 g), and 16 patients weighed 1500 g or less. Median gestational age at birth was 34 weeks, and 66 patients were born prematurely (before 37 weeks' estimated gestational age). Median age at the operation was 16 days (range 1 day to 4.6 months). Demographic data are summarized in Table I.
|
Data collection and analysis
Perioperative data were obtained through retrospective review of hospital records. Cross-sectional follow-up was performed during the period from September to December 1997 and was complete for all but 2 patients, who were unavailable for follow-up. Follow-up information, including patient clinical status, weight, medications, and echocardiographic and cardiac catheterization data, was obtained by direct physician or parent contact.
Data are expressed as median and range or mean and SD unless otherwise specified. Comparisons of means between 2 groups were performed with the independent samples t test, and comparisons of dichotomous variables between 2 groups were performed with
2 analysis. Actuarial survival analysis and assessment of independent variables correlating with poor survival were performed with the Kaplan-Meier product limit method and Cox proportional hazards regression (univariate and multivariate), respectively. Outcome measures analyzed were perioperative mortality (death during postoperative hospitalization or within 30 days, whichever was longer), late survival, and freedom from reintervention. Preoperative and operative variables analyzed for correlation with outcomes included age, gestational age at birth, birth weight, weight at the operation, time from referral to the operation, diagnosis, complex lesion (defined in Table II), preoperative morbidity, associated syndromes or congenital malformations, cardiopulmonary bypass time, and postoperative open sternotomy. Statistical analysis was performed with SPSS for Windows 6.01 (SPSS Inc, Chicago, Ill).
|
| Results |
|---|
|
|
|---|
|
|
|
Early reinterventions. Five early interventions were performed in 3 patients. One patient (after repair of Taussig-Bing double-outlet right ventricle and interrupted aortic arch) had a right atrial thrombus develop in association with a central venous catheter and required reoperation to evacuate the clot. Later this patient required closure of an atrial septal defect, which had intentionally been left open during the operation to serve as a pop-off right-to-left atrial communication. One patient, in whom a Damus-Kaye-Stansel type of repair was performed for Taussig-Bing anomaly with coarctation of the aorta, acquired native aortic regurgitation and underwent subaortic patch closure of the left ventricular outflow tract. In this same patient a residual left-to-right shunt through the right ventricular trabeculae was closed with coils. One patient underwent reexploration and débridement for mediastinitis.
Other perioperative morbidity. Significant perioperative complications included cardiac arrest in the operating room before the operation (n = 1; the patient required extracorporeal membrane oxygenation after repair), complete atrioventricular block (n = 1), temporary phrenic nerve palsy (n = 3), central venous thrombus formation (n = 2), colonic perforation (n = 1), mediastinitis (n = 1), and transient seizures (n = 3). All 3 patients with transient seizures had a seizure disorder diagnosed before the operation. Four patients acquired sepsis with positive blood culture results and were treated successfully with antibiotics. No patient showed signs of new neurologic abnormalities.
Resource use. Postoperative mechanical ventilation was required for 1 to 75 days (median 5 days). Duration of stay in the intensive care unit ranged from 1 to 85 days (median 9 days). The duration of hospitalization ranged from 5 to 105 days (median 19 days).
Late results
Follow-up and growth. Follow-up was complete for 88 of 90 early survivors; the other 2 patients were unavailable for follow-up. Follow-up duration ranged from 9 to 54 months (median 30 months). In the cases of 54 survivors for whom copies of the primary pediatrician's growth charts were available, median weight was at the 10th percentile for age-matched healthy children (range <2nd-55th percentile). None of the surviving patients has clinical evidence of postoperative neurologic abnormalities.
Late mortality rate. There were 8 late deaths (9% of early survivors). Of these, 4 were of cardiac causes and 4 were of noncardiac causes. One patient died 3 months after the operation of progressive pulmonary venous obstruction of individual pulmonary veins, which had not been present at the time of the original repair. Serial echocardiograms documented the onset and progression of this problem after the initial operation. One patient died 5 months after the operation of right ventricular failure that developed as the patient outgrew the small right ventricular outflow tract conduit that was placed at the initial operation. This patient did not undergo timely reintervention to replace the conduit. In 1 patient severe subaortic left ventricular outflow tract obstruction developed after repair of an interrupted aortic arch. At reoperation 3 months after the initial repair the patient went into cardiac arrest at anesthesia induction and could not be saved. One patient in whom recent echocardiography had shown no residual defects or cardiac dysfunction died of sudden infant death syndrome 11 months after the operation. One patient died 6 months after the operation of intractable sepsis related to a bowel stricture. This patient had acquired necrotizing enterocolitis during the period of attempted medical management before referral for cardiac surgery. At the time of the operation the necrotizing enterocolitis had resolved; however, a late stricture developed. One patient died after reoperation for mitral valve replacement and subaortic obstruction. This patient, who initially was seen with coarctation and later proved to have the Shone complex, had intractable bleeding after the reoperation and could not be separated from bypass. One patient with familial distichiasis lymph-edema syndrome acquired fungal sepsis and died 2 months after the operation. One patient with tetralogy of Fallot, major aorta-pulmonary collaterals, and DiGeorge syndrome was readmitted to the hospital several times with pulmonary infections and died of sepsis 6 months after the operation.
Actuarial survival was 82% at 1 year and beyond (Fig. 2). Of the factors analyzed for association with poorer survival across time by univariate Cox regression, longer cardiopulmonary bypass time (P = .002), complex anomalies (P = .03), and a diagnosis of truncus arteriosus (P = .03) were found to correlate to a statistically significant degree. When these were entered into multivariate Cox regression analysis, only longer cardiopulmonary bypass time remained significant (P = .001).
|
Actuarial freedom from reintervention was 91% at 1 year and beyond (Fig. 2
). None of the preoperative and operative factors analyzed correlated with shorter freedom from reintervention.
Residual or new cardiac lesions. Follow-up echocardiography performed at a median of 29 months (range 9-51 months) after initial repair revealed the following abnormalities. One patient had mild aortic regurgitation 48 months after an arterial switch operation. Two patients who had undergone repair of tetralogy of Fallot (1 with pulmonary atresia) 15 and 17 months earlier had mild pulmonary stenosis and moderate pulmonary regurgitation. One patient had mild residual coarctation with moderate hypoplasia of the distal arch 40 months after repair of aortic coarctation. A patient who had undergone repair of complete atrioventricular septal defect was found to have mild mitral regurgitation 46 months after the operation. A patient with truncus arteriosus had moderate to severe (gradient of 70 mm Hg) conduit stenosis develop 44 months after the operation. Two patients who underwent repair of interrupted aortic arch had subaortic stenosis with gradients of 40 and 50 mm Hg 12 and 15 months after the operation, respectively.
Follow-up cardiac medications. At the time of cross-sectional follow-up 8 patients were taking cardiac medications. These included furosemide (n = 4), digoxin (n = 2), captopril (n = 1), and nifedipine (n = 1).
| Discussion |
|---|
|
|
|---|
Our experience suggests that complete repair not only of simple and moderately complex heart defects but even of highly complex heart defects can be achieved with good results in patients who weigh less than 2500 g. There were 10 early deaths in our series. Although cardiopulmonary bypass and aortic crossclamp times were significantly longer for patients who died than for those who survived, it is likely that the mortality rate was not associated with bypass and cardioplegic arrest per se but was associated with the higher complexity of the lesions that required this prolonged circulatory support. Longer cardiopulmonary bypass time was also the only independent risk factor for poorer survival across time. Of the 8 late deaths, 4 were related to cardiac causes and 4 were of noncardiac causes. Two deaths were preventable and 1 was related to progression of uncorrectable disease.
Chang and colleagues
10 reported on a series of 100 low birth weight and premature patients with congenital heart disease who were managed with different protocols. Among patients in whom intervention was performed early the mortality rates were 18% with corrective procedures and 22% with palliative procedures. In the group in which intervention was delayed, there was a 23% interim mortality rate. We agree with Chang and colleagues
10 that delayed intervention does not confer any benefit and may in fact increase morbidity and mortality. In our experience delay in intervention was associated with increased complications, including ventilatory dependency, failure to thrive, absence of weight gain, sepsis, chronic pulmonary disease, necrotizing enterocolitis, and acute renal failure.
Previous reports have not addressed the issue of late complications and reinterventions after cardiac operations in premature and low birth weight infants. Our experience suggests that these occur at rates similar to those after operations on term neonates. It is necessary to closely follow up patients who have received conduits, because conduits implanted in these patients are generally small (in this series the allograft conduits were all
10 mm in diameter). Similarly, patients with interrupted aortic arch commonly have subaortic left ventricular outflow tract obstruction develop. Both of these situations led to a late death in our series, which illustrates the need for aggressive and objective cardiac evaluation in this group of patients to ensure that timely intervention can be performed.
It is logical to assume that correcting the cardiac defect will influence the cardiovascular physiology toward normal status and may be beneficial to pulmonary and other organ systems. There is evidence that growth is better after earlier repair of congenital heart lesions than after later repair.
11 On the basis of weight gains observed in patients in this study, it appears that growth is also improved in premature and low birth weight infants who undergo early cardiac operative repair. Growth is similar to that seen among low birth weight and premature babies without cardiac disease, with babies with lower birth weights at lower percentiles of growth.
12 There is an extensive body of literature dealing with the issue of neurologic development in low birth weight and premature babies, and it is clear that the incidence of developmental impairment rises with decreasing birth weight in this group of infants.
12 It is reasonable to assume that development after surgical repair of congenital heart lesions, at least among those children without associated syndromes, will be brought to a level comparable to that observed among neonates of similar birth weight with no congenital cardiac anomalies. Although we did not specifically investigate every patient for perioperative intracerebral hemorrhage, no major neurologic complications were encountered that would suggest cerebral bleeding after bypass. Also, we currently make all efforts to avoid the use of circulatory arrest to prevent any possible attendant neurologic complications.
Delay in referral for intervention remains among the most persistent difficulties in the overall management of these infants. The reluctance to refer patients for surgical correction appears to be due to the widely prevalent notion that surgery requiring cardiopulmonary bypass in these patients carries an inordinately high risk of death or morbidity. It seems, however, that this trend has started to change significantly in recent years. We cannot definitively resolve the question of whether risk of repair is equivalent or higher for premature infants than for term infants with the same lesions; however, this is not really the relevant issue. Even if one believes that prematurity or low birth weight does carry increased risk, the more relevant question is how the risk of repair compares to the risk of care involving medical management and delay in repair. Our results indicate that early repair carries lesser morbidity and that delay in repair carries extraordinary morbidity. We currently encourage referral for corrective surgery early after diagnosis if failure to thrive is present. Early intervention may also favorably affect the cost of care for these patients.
Complete repair of simple and moderately complex congenital heart defects can be performed safely and effectively in premature and low birth weight infants. In our experience even extremely complex lesions can be repaired effectively. An argument might be made that repair in the premature infant of some of these extremely complex lesions, such as double homograft repairs, may not be the most efficient use of resources. This becomes a philosophic or economic argument. Without taking a strong position on this issue, our success with these complex cases does underscore the point that the simpler lesions should be approached more aggressively with the anticipation of reliable outcome.
| Appendix: Discussion |
|---|
|
|
|---|
At the Royal Children's Hospital in Melbourne from 1979 to 1990, we reported the cases of 60 patients smaller than 2.5 kg, with a mean weight of 2.1 kg and a mean gestational age of 34 weeks. These were all patients who underwent cardiac operations, and they also included patients who underwent palliative heart operations. The early and late mortality rates for this group of 60 patients were 16% and 13%, respectively. If we took out the univentricular repairs on cardiopulmonary bypass, the mortality rate fell to 12%. In that univentricular group the mortality rate was 50%, as in your own experience. During a similar period from 1984 to 1990, however, 296 neonates of all ages underwent biventricular repair on cardiopulmonary bypass with a mortality rate of 2%. I can add that in my more recent experience at the Cleveland Clinic I think we have seen some further improvement. For heart repair of infants smaller than 2.5 kg from 1993 to 1998, whether univentricular or biventricular repair, the mortality rate is now 5%. For biventricular repair in older neonates, however, it remains 2% or less. I therefore think that age is still a risk factor.
In the last 15 to 20 years there have been important improvements in specialization in congenital heart disease and in surgery for these conditions. I think of most importance was the development of small-body technology, particularly the understanding of perfusion in small bodies. This leads me to some questions. The Melbourne method and the Cleveland Clinic method have also avoided circulatory arrest wherever possible and do these repairs on cardiopulmonary bypass. Our approach has been a little different, however. We have used aggressive
-adrenergic blockade and high-flow, low-pressure cardiopulmonary bypass. If you are concerned about circulatory arrest, what is the logic of using low-flow cardiopulmonary bypass when you have already cannulated to do the operation under cardiopulmonary bypass?
Also, can you derive from your experience the impact of tracheobronchomalacia or bronchopulmonary dysplasia in these small babies? In our experience this had a profound effect on the long-term results. I wonder whether in your outliers, in terms of time in intensive care and time in the hospital, this was an important point. If these children already have these problems, then the repair of their cardiac lesions may not make too much difference in the time that they have to spend on a ventilator and the time in intensive care.
I also wonder you why you included 14 closed procedures in this report, in which the focus is clearly on how to do cardiopulmonary bypass in very small babies. Can you separate out the mortality rate for those closed procedures from that for the open procedures?
Finally, we agree with you entirely about the apparently low risk, which is a surprise, for intracerebral hemorrhage associated with cardiopulmonary bypass in these children. How would you manage a small baby who has a high-flow lesion and is known to have an intraventricular hemorrhage? How long do you wait before performing cardiopulmonary bypass?
Dr Reddy. First, I do not contest the fact that age and weight still remain important risk factors in this group of patients. Our message was that waiting carries a higher morbidity and risk. The risk of surgery certainly is more than for a neonate with the normal birth weight. As your own data demonstrate, with experience your mortality rate dropped to 5%. The mortality rate is going to decrease further, as we have seen with neonatal cardiac surgery.
To address your questions, we routinely use deep hypothermia with low-flow cardiopulmonary bypass. We also use
-adrenergic blockers, namely phentolamine hydrochloride (INN: phentolamine), for cooling and rewarming. We prefer to use low-flow bypass rather than high flow because there is no evidence to suggest that higher flows are beneficial during deep hypothermia. Low-flow bypass is adequate for tissue oxygenation and keeps the surgical field relatively dry. Since the cannulas are in place, the amount of bypass flow is a matter of surgeon preference until there is evidence to suggest one technique is beneficial.
We included the nonpump cases to report our total experience. Even if you exclude the 14 nonpump cases in this report, 88 patients still have undergone complete repairs of complex lesions with an 11% mortality.
Tracheomalacia is an important cause of morbidity and did result in prolonged ventilatory support in some patients. Also, I think chronic lung disease can be minimized by early repair of complex heart defects in these small babies.
Intracranial bleeding often has been an important concern with the neonatologists. We certainly agree with your experience that intracranial bleeding has not been an issue with our group. With respect to the question of when should we operate if a patient has a hemorrhage, I think that there are no data on the group of patients who have had recent hemorrhage. I would say that waiting for a few days may be sufficient if the patient has symptoms. If the patient has no symptoms, however, I think one should wait at least 1 or 2 weeks before doing the open procedure with cardiopulmonary bypass.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
H M Gardiner The case for fetal cardiac intervention Heart, October 15, 2009; 95(20): 1648 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El-Sisi, A. Khella, M. Numan, M. Dilwar, A. Bhat, and A. Soliman Linear Growth in Relation to the Circulating Concentration of Insulin-like Growth Factor-I and Free Thyroxine in Infants and Children with Congenital Cyanotic Heart Disease Before vs. After Surgical Intervention J Trop Pediatr, October 1, 2009; 55(5): 302 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Burch, C. G. Cowley, R. Holubkov, D. Null, L. M. Lambert, P. C. Kouretas, and J. A. Hawkins Coarctation repair in neonates and young infants: Is small size or low weight still a risk factor? J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyamoto, N. Sinzobahamvya, J. Photiadis, A. M Brecher, and B. Asfour Survival after Surgery with Cardiopulmonary Bypass in Low Weight Patients Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 115 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Curzon, S. Milford-Beland, J. S. Li, S. M. O'Brien, J. P. Jacobs, M. L. Jacobs, K. F. Welke, A. J. Lodge, E. D. Peterson, and J. Jaggers Cardiac surgery in infants with low birth weight is associated with increased mortality: Analysis of the Society of Thoracic Surgeons Congenital Heart Database J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 546 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Vogt, C. Manlhiot, G. Van Arsdell, J. L. Russell, S. Mital, and B. W. McCrindle Somatic Growth in Children With Single Ventricle Physiology: Impact of Physiologic State J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1876 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Bakshi, B. Vaidyanathan, K. R. Sundaram, S. J. Roth, K. Shivaprakasha, S. G. Rao, S. G. Nair, S. Chengode, and R. K. Kumar Determinants of early outcome after neonatal cardiac surgery in a developing country J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 765 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roussin, E. Belli, J. Bruniaux, S. Demontoux, A. Touchot, C. Planche, and A. Serraf Surgery for Transposition of the Great Arteries in Neonates Weighing Less Than 2,000 Grams: A Consecutive Series of 25 Patients Ann. Thorac. Surg., January 1, 2007; 83(1): 173 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Abrishamchian, D. Kanhai, E. Zwets, L. Nie, and M. Cardarelli Low birth weight or diagnosis, which is a higher risk? -- a meta-analysis of observational studies Eur. J. Cardiothorac. Surg., November 1, 2006; 30(5): 700 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Bleiweis and A. Saidi Advances in Neonatal Cardiac Surgery: Historical Perspective and Current Status NeoReviews, September 1, 2006; 7(9): e463 - e473. [Full Text] [PDF] |
||||
![]() |
C. D. Sudarshan, A. D. Cochrane, Z. H. Jun, R. Soto, and C. P. Brizard Repair of coarctation of the aorta in infants weighing less than 2 kilograms. Ann. Thorac. Surg., July 1, 2006; 82(1): 158 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laudito, V. M. Bandisode, J. F. Lucas, W. A. Radtke, W. T. Adamson, and S. M. Bradley Right Ventricular Outflow Tract Stent as a Bridge to Surgery in a Premature Infant with Tetralogy of Fallot Ann. Thorac. Surg., February 1, 2006; 81(2): 744 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeda, T. Asou, N. Yamamoto, K. Ohara, H. Yoshimura, and H. Okamoto Arch Reconstruction without Circulatory Arrest in Neonates Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 337 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Ades and G. Wernovsky Management Considerations and Outcomes of Low-birthweight Infants Who Have Congenital Heart Disease NeoReviews, July 1, 2005; 6(7): e332 - e338. [Full Text] [PDF] |
||||
![]() |
A. Lammers, A. Hager, A. Eicken, R. Lange, M. Hauser, and J. Hess Need for closure of secundum atrial septal defect in infancy J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1353 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Dorfman, J. C. Levine, S. D. Colan, and T. Geva Accuracy of Echocardiography in Low Birth Weight Infants With Congenital Heart Disease Pediatrics, January 1, 2005; 115(1): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Oppido, C. P. Napoleone, R. Formigari, D. Gabbieri, D. Pacini, G. Frascaroli, and G. Gargiulo Outcome of cardiac surgery in low birth weight and premature infants Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 44 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bove, K. Francois, K. De Groote, B. Suys, D. De Wolf, H. Verhaaren, D. Matthys, A. Moerman, J. Poelaert, P. Vanhaesebroeck, et al. Outcome analysis of major cardiac operations in low weight neonates Ann. Thorac. Surg., July 1, 2004; 78(1): 181 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lee, B. Ovadia, A. Azakie, S. Salas, J. Goerke, J. R. Fineman, and J. A. Gutierrez Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of life Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1237 - L1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Duncan, N. C. Poirier, R. B. B. Mee, J. J. Drummond-Webb, A. Qureshi, C. I. Mesia, J. A. Graney, C. L. Malek, and L. A. Latson Selective timing for the arterial switch operation Ann. Thorac. Surg., May 1, 2004; 77(5): 1691 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takayama, A. Sekiguchi, M. Chikada, M. Noma, A. Ishizawa, and S. Takamoto Mortality of pulmonary artery banding in the current era: recent mortality of PA banding Ann. Thorac. Surg., October 1, 2002; 74(4): 1219 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Kecskes and D W Cartwright Poor outcome of very low birthweight babies with serious congenital heart disease Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2002; 87(1): F31 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McElhinney, S.-G. Yang, A. N. Hogarty, J. Rychik, M. M. Gleason, C. H. Zachary, J. J. Rome, T. R. Karl, W. M. DeCampli, T. L. Spray, et al. Recurrent arch obstruction after repair of isolated coarctation of the aorta in neonates and young infants: Is low weight a risk factor? J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 883 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bacha, M. Almodovar, D. L. Wessel, D. Zurakowski, J. E. Mayer Jr, R. A. Jonas, and P. J. del Nido Surgery for coarctation of the aorta in infants weighing less than 2 kg Ann. Thorac. Surg., April 1, 2001; 71(4): 1260 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McElhinney, H. L. Hedrick, D. M. Bush, G. R. Pereira, P. W. Stafford, J. W. Gaynor, T. L. Spray, and G. Wernovsky Necrotizing Enterocolitis in Neonates With Congenital Heart Disease: Risk Factors and Outcomes Pediatrics, November 1, 2000; 106(5): 1080 - 1087. [Abstract] [Full Text] |
||||
![]() |
F. Haas, C. S. Goldberg, R. G. Ohye, R. S. Mosca, and E. L. Bove Primary repair of aortic arch obstruction with ventricular septal defect in preterm and low birth weight infants Eur. J. Cardiothorac. Surg., June 1, 2000; 17(6): 643 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Picarelli, J. Surraco, C. Zuniga, C. Peluffo, R. Anzibar, J. Tambasco, R. Leone, J. Nozar, and P. Duhagon SURGICAL MANAGEMENT OF ACTIVE INFECTIVE ENDOCARDITIS IN A PREMATURE NEONATE WEIGHING 950 GRAMS J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 380 - 381. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |